Sadat-Ali Mir, Al-Habdan Ibrahim M, Al-Turki Haifa A, Azam Mohammed Quamar
PO Box 40071 King Fahd University Hospital Al-Khobar 31952 Saudi Arabia.
Ann Saudi Med. 2012 Nov-Dec;32(6):637-41. doi: 10.5144/0256-4947.2012.637.
Osteoporosis is common in Saudi Arabia and the burden of management in an aging population will increase in coming decades. There is still no national policy nor consensus on screening for this silent disease. The objective of this analysis was to determine from the published data the prevalence of osteopenia and osteoporosis in Saudi Arabians, the prevalence of secondary osteoporosis, and the prevalence of osteoporosis-related fractures (ORF). We also sought to determine the best age to begin and best modality for screening.
Data Sources were MEDLINE (1966 to May 2011), EMBASE (1991 to May 2011), the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (1952 to May 2011), and the Science Citation Index (1966 to May 2011), published data from the Saudi Medical Journal (1985-2011) and Annals of Saudi Medicine (1985-2011). We selected English-language articles with at least 100 Saudi individuals. Two authors independently reviewed articles and abstracted data.
The authors identified 36 potentially relevant articles, of which 24 met the inclusion criteria. Of 5160 healthy women 50 to 79 years of age (mean, SD: 56.8 [2.7]), 36.6% (6.6%) were osteopenic and 34.0% (8.5%) were osteoporotic. In three studies on males (n=822), the prevalence of osteopenia was 46.3% and osteoporosis 30.7%. Males had a significantly higher frequency of osteopenia in comparison to females (P= < .001 95% CI < -0.0333), The mean age of the patients with secondary osteoporosis was 37.4 (13.5, 18-57) years, with the osteoporosis in 46.4% and osteopenia in 34.1%. In 5 studies of ORF, the incidence of vertebral fractures was between 20%-24%.
The currently available literature on Saudi Arabian population suggests that the ideal age for screening for low bone mass among the Saudi population should be earlier (55 years) than the >=65 years in Western countries. Both quatitative ultrasound and dual-energy x-ray absorptiometry could be used for screening. The relatively small number of studies on Saudi Arabians and the different machines used for diagnosis limited the authors ability make conclusions with surety.
骨质疏松症在沙特阿拉伯很常见,在未来几十年里,老龄化人口的管理负担将会增加。对于这种隐匿性疾病的筛查,该国仍没有国家政策,也未达成共识。本分析的目的是根据已发表的数据,确定沙特阿拉伯人骨质减少和骨质疏松症的患病率、继发性骨质疏松症的患病率以及骨质疏松症相关骨折(ORF)的患病率。我们还试图确定开始筛查的最佳年龄和最佳筛查方式。
数据来源包括MEDLINE(1966年至2011年5月)、EMBASE(1991年至2011年5月)、Cochrane对照试验中央注册库和Cochrane系统评价数据库(1952年至2011年5月)以及科学引文索引(1966年至2011年5月),还有《沙特医学杂志》(1985 - 2011年)和《沙特医学年鉴》(1985 - 2011年)发表的数据。我们选择了至少有100名沙特人的英文文章。两位作者独立审阅文章并提取数据。
作者识别出36篇可能相关的文章,其中24篇符合纳入标准。在5160名50至79岁的健康女性中(平均年龄,标准差:56.8 [2.7]),36.6%(6.6%)为骨质减少,34.0%(8.5%)为骨质疏松。在三项关于男性的研究中(n = 822),骨质减少的患病率为46.3%,骨质疏松的患病率为30.7%。与女性相比,男性骨质减少的发生率显著更高(P = <.001,95% CI < -0.0333)。继发性骨质疏松症患者的平均年龄为37.4(13.5,18 - 57)岁,其中骨质疏松症患者占46.4%,骨质减少患者占34.1%。在5项关于ORF的研究中,椎体骨折的发生率在20% - 24%之间。
目前关于沙特阿拉伯人群的文献表明,沙特人群中筛查低骨量的理想年龄应比西方国家的≥65岁更早(55岁)。定量超声和双能X线吸收法均可用于筛查。关于沙特阿拉伯人的研究数量相对较少,且用于诊断的机器不同,这限制了作者得出确定性结论的能力。